Glen Eagle Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-40
| Closed | -$3.49K | – | 1016 |
|
|
2021
Q3 | $3.49K | Sell |
40
-7
| -15% | -$611 | ﹤0.01% | 853 |
|
|
2021
Q2 | $7.22K | Sell |
47
-7
| -13% | -$1.08K | ﹤0.01% | 757 |
|
|
2021
Q1 | $8.52K | Hold |
54
| – | – | ﹤0.01% | 688 |
|
|
2020
Q4 | $12.5K | Buy |
54
+7
| +15% | +$1.63K | ﹤0.01% | 594 |
|
|
2020
Q3 | $10.4K | Buy |
47
+24
| +104% | +$5.29K | ﹤0.01% | 590 |
|
|
2020
Q2 | $6.44K | Buy |
+23
| New | +$6.44K | ﹤0.01% | 629 |
|